Research reveals possible new treatment pathway for severe allergic asthma

October 13, 2017

Research demonstrates that blocking the action of two pro-inflammatory molecules significantly reduces symptoms of allergic asthma in mice, which could lead to development of a new treatment for people with a severe form of the condition.

The findings, which are published in the journal Clinical Science, show that severe allergic lung inflammation was significantly reduced in the mice when the activity of the pro-inflammatory interleukin (IL)-17A and IL-17F was prevented using specific antibodies.

"Blocking either of these molecules stopped symptoms of in mice and we hope this could lead to development of a new therapy for severe (Th17) allergic in humans," commented senior author Bernhard Ryffel from the CNRS-University of Orleans, France.

Asthma is a common inflammatory lung condition of varying severity. Asthma and allergies are frequently linked and people with allergic asthma can have flare-ups or attacks in response to exposure to certain environmental factors such as house .

During an attack of allergic asthma, immune cells known as T-helper cells respond to inhaled allergens and trigger the production of pro-inflammatory molecules that lead to the symptoms seen in asthma such as constricted airways and wheezing.

"Severe allergic asthma with neutrophils is due to increased IL-17A expression produced by T-helper 17 cells," explained Ryffel.

In this study, the researchers first exposed mice to house dust mites and found that production of pro-inflammatory IL-17A and IL-17F was triggered in the lungs of the animals.

In further experiments, they found mice that could not genetically produce either IL-17A or IL-17F, or a protein called IL-17RA that binds to these molecules, had a smaller allergic response to house dust mites than animals that could produce both molecules.

To test these results further, the researchers used anti-IL-17A and -IL-17F antibodies as a treatment in mice experiencing a respiratory allergic reaction to house dust mites. They found that the allergic immune response and asthma symptoms were dramatically reduced in these , suggesting if these findings can be replicated in humans that they could lead to a new treatment for allergic asthma attacks.

"The results are relevant for clinical use of specific antibodies or related inhibitorsin IL-17RA dependent severe asthma, suggesting equal efficacy using either agonist orreceptor blockade to treat severe asthma crisis," said Ryffel.

Dr Karl Staples (University of Southampton, UK), an expert on allergic asthma who was not involved in the research, commented: "Historically, IL-17 has been thought to be an anti-bacterial program of immunity. This work demonstrates that there is also an intimate link with the allergic program and specifically with airway hyper-responsiveness.

"Much further work in both models and humans is required to fully untangle this complex web of immune responses. The evidence presented further suggests that IL-17 is necessary only for the initial sensitization to allergen and may therefore explain the recent finding that an IL-17RA antibody was unable to affect established asthma symptoms in a recent clinical trial."

Explore further: Offspring of female mice exposed to e-cigarettes have increased risk of allergic asthma

More information: Pauline Chenuet et al, Neutralization of either IL-17A or IL-17F is sufficient to inhibit house dust mite induced allergic asthma in mice, Clinical Science (2017). DOI: 10.1042/CS20171034

Related Stories

Offspring of female mice exposed to e-cigarettes have increased risk of allergic asthma

September 12, 2017
Researchers have found that maternal e-cigarette vaping is linked to an increased risk of allergic asthma in offspring. The study was carried out in mice, but Dr Pawan Sharma, Chancellors Fellow and Research Leader in the ...

Bacterial protein in house dust spurs asthma, according to new study

October 15, 2012
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the ...

Testosterone explains why women more prone to asthma

May 8, 2017
An international research team has revealed for the first time that testosterone protects males against developing asthma, helping to explain why females are two times more likely to develop asthma than males after puberty.

Subset of immune cells linked to allergic rhinitis symptoms

August 10, 2017
Have you ever suffered from asthma or know someone who does? It is excruciating to watch them suffer. An asthma attack makes something as simple as breathing, extremely difficult. I have seen this first hand with my mum, ...

Scientists unearth cell 'checkpoint' that stops allergic diseases

August 9, 2017
Scientists from Trinity College Dublin have made a significant breakthrough in understanding the regulation of immune cells that play a pivotal role in allergic diseases such as asthma and eczema. They have identified a 'checkpoint' ...

Asthma in many adolescents is not an allergic disease

January 13, 2016
New research indicates that asthma in many adolescents is not likely to involve inflammation of the airways and therefore should not be considered an allergic disease.

Recommended for you

Immune cells turn back time to achieve memory

December 13, 2017
Memory T cells earn their name by embodying the memory of the immune system - they help the body remember what infections or vaccines someone has been exposed to. But to become memory T cells, the cells go backwards in time, ...

Steroid study sheds light on long term side effects of medicines

December 13, 2017
Fresh insights into key hormones found in commonly prescribed medicines have been discovered, providing further understanding of the medicines' side effects.

The immune cells that help tumors instead of destroying them

December 12, 2017
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

Researchers bring new insight into Chediak-Higashi syndrome, a devastating genetic disease

December 12, 2017
A team of researchers from the National Institutes of Health and University of Manchester have uncovered new insights into a rare genetic disease, with less than 500 cases of the disease on record, which devastates the lives ...

Drug increases speed, safety of treatment for multiple food allergies

December 11, 2017
In a randomized, controlled phase-2 clinical trial, an asthma medication increased the speed and safety of a protocol used to treat children for several food allergies at once, according to a study by researchers at the Stanford ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.